New risk assessment for Boston biocontainment lab

New risk assessment for Boston biocontainment lab

A US National Institutes of Health advisory panel has released a new risk assessment for a controversial high-security biocontainment lab located near  Boston’s bustling downtown core. The Draft Supplementary Risk Assessment for the Boston University National Emerging Infectious Diseases Laboratories (NEIDL) was released on 24 February and is the next step in a long and process that may eventually lead to the National Biocontainment Laboratory being used for its intended purpose:  researching vaccines, therapeutics and diagnostics for emerging biological agents that could pose a serious public threat.  Read more

‘Report card’ documents the Arctic’s new normal

'Report card' documents the Arctic's new normal

The Arctic has entered a new era. The region has shifted to conditions of warmer air and water, less ice covering the sea and more vegetation growing on the land, say an international team of scientists in this year’s Arctic Report Card from the US National Oceanic and Atmospheric Administration.

New neurons reduce drug-seeking behaviour

New neurons reduce drug-seeking behaviour

Some of the hard work of fighting addiction to heroin or cocaine is in learning not to use the drug. And if drug use inhibits the generation of new neurons that facilitate learning, the problem becomes a vicious circle. Now, research presented at this week’s annual meeting of the Society for Neuroscience in Washington DC shows that increasing the brain’s ability to generate new neurons decreases drug-seeking behaviours in rodents.